1 / 6

R&I: Epilepsy Market in the US - Size, Growth, Forecast 2019

Epilepsy Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Epilepsy Market in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Detailed report at: http://www.reportsandintelligence.com/epilepsy-in-the-us-2015-2019-market

gretaparker2014
Download Presentation

R&I: Epilepsy Market in the US - Size, Growth, Forecast 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Epilepsy Market in the US Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Growth, Forecast 2015-2019 Published By : Technavio Published On : January, 2015

  2. Description About Epilepsy Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying cause of the disease is unidentified, as in the majority of the cases, it is known as idiopathic epilepsy. Epilepsy is characterized by repeated occurrence of generalized or focal seizures. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures. Occurrence of two or more unprovoked seizures is an important criterion to diagnose a person as being epileptic. TechNavio's analysts forecast the Epilepsy market in the US to grow at a CAGR of 4.85 percent over the period 2014-2019.

  3. Description Covered in this Report The Epilepsy market in the US can be divided into three segments: First-generation Drugs, Second-generation Drugs, and Third-generation Drugs. This report covers the present scenario and the growth prospects of the Epilepsy market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of anti-epileptic drugs approved in the US to treat the symptoms of epilepsy. TechNavio's report, Epilepsy Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Epilepsy Market in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. For more inquiry, visit at: http://www.reportsandintelligence.com/enquire-about-report/170001

  4. KeyVendors Pfizer GlaxoSmithKline UCB

  5. Table of Content • 01. Executive Summary • 02. List of Abbreviations • 03. Scope of the Report • 04. Market Research Methodology • 05. Disease Overview • 06. Introduction • 07. Market Landscape • 08. Market Segmentation by Generation of Drugs • 09. Buying Criteria • 10. Market Growth Drivers • Get full TOC at: http://www.reportsandintelligence.com/epilepsy-in-the-us-2015-2019-market/table-of-contents

  6. FOR MORE DETAILS Visit us at : http://www.reportsandintelligence.com/epilepsy-in-the-us-2015-2019-market Stay With Us: • TELEPHONE: Direct: +1 (617) 674-4143 • Toll Free: +1 (855) 711-1555E-MAIL: sales@reportsandintelligence.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related